Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

News and Trends 10 Jul 2017

Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s

Prexton Therapeutics has launched a Phase II trial to test whether its drug foliglurax can treat the motor complications of standard levodopa therapy. The Phase II trial will enroll 165 patients across the UK, Germany, France, Austria, Spain and Italy to monitor the effects of Prexton’s foliglurax. The company is looking for patients that have been treated […]

July 10, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Jul 2017

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is aiming high in an IPO on the US Nasdaq. Zealand Pharma has announced it has already filed for an IPO at the Nasdaq Global Select Market, an exclusive listing for large cap companies. Currently listed on the Nasdaq Copenhagen, Zealand Pharma […]

July 10, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 10 Jul 2017

Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi

Alnylam and its partner Sanofi are starting a Phase III program to enter its RNAi drug fitusiran in the competitive hemophilia market. Sanofi and its partner Alnylam have announced the start of a Phase III program that seeks to recruit 250 patients to test its RNAi drug fitusiran in patients with both hemophilia A and […]

July 10, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Minoryx Therapeutics Marc Martinell interview

Interview 10 Jul 2017

Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease

I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in Barcelona is bringing new hope for patients suffering from rare diseases. Having previously worked in Crystax Pharmaceuticals and Oryzon Genomics, Marc Martinell is now CEO of one of Spain’s most successful biotechs. Minoryx Therapeutics is developing what could be the first […]

July 10, 2017 - 6 minutesmins - By Clara Rodríguez Fernández

Margherita Pevere bacterial cellulose bioart

News and Trends 8 Jul 2017

Memories Encoded in DNA and Biological Reliques

Margherita Pevere is an artist that uses living organisms to explore our relationship with nature and technology, and our obsession with preserving information. Margherita Pevere is an artist fascinated by the connection between humans and nature, and how the pervasive introduction of technology into all aspects of our lives is affecting this relationship. Her work puts living […]

July 8, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Cellnovo type 1 diabetes artificial pancreas

News and Trends 7 Jul 2017

French Mobile Diabetes Firm gets €17.5M to Build an Artificial Pancreas

Cellnovo has launched a capital increase from top European investors to boost its mobile system for diabetes and complete the development of a fully automated artificial pancreas. Cellnovo is a French medtech company with an all-in-one system to manage diabetes in the market. The company has now announced a capital raise of €17.5M to boost […]

July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Startup Scout 7 Jul 2017

A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections

This week we’re traveling to Bergen, a beautiful coastal city in Norway surrounded by seven mountains, where a biotech called Cytovation is developing a brand new treatment for benign tumors caused by the human papillomavirus. Mission: Cytovation is developing what could be the first prescription treatment for cutaneous warts, which are a form of […]

July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Startup Battle Labiotech Refresh 2017 Rising Stars

Interview 6 Jul 2017

Watch Europe’s Rising Biotech Startups Battle it out at Refresh

After the early stage startups gave it all on stage, it was the turn of the more advanced biotechs to fight each other at Labiotech Refresh 2017. The first contestant was Beroceutica, a startup from Germany that uses artificial intelligence to look for biomarkers that allow better patient stratification in clinical trials. The goal is to increase the success […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

liver transplant cambridge university research

More News! 6 Jul 2017

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

A new study describes a method that could be used to regenerate bile ducts in children with biliary atresia instead of waiting for a liver transplant. Researchers at the University of Cambridge might have found an alternative to transplant for children with liver disease. Their results, published today in Nature Medicine, reveal that primitive bile ducts grown […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Jul 2017

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in Ireland, and its partner Roche have announced the first patient has been enrolled in a Phase II trial testing an antibody treatment for Parkinson’s. Reaching […]

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

universal cancer vaccine mrna biontech personalized medicine

News and Trends 5 Jul 2017

Results are in from the First Human Trial of an Universal Cancer Vaccine

BioNTech has published results from the first clinical trial for an mRNA-based individualized vaccine with the potential to target all cancer types. Published in Nature, the results from the first trial in humans with a personalized mRNA cancer vaccine hint that BioNTech is on a promising track towards the development of a universal cancer vaccine. All […]

July 5, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Jul 2017

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of indications in filgotinib’s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotinib. The small molecule is already in Phase III for rheumatoid arthritis, Crohn’s disease and ulcerative colitis. The team is now launching a new Phase II trial in […]

July 5, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Clara Rodríguez Fernández

About

Articles by Clara Rodríguez Fernández

Swiss Biotech Starts Phase II Trial to Treat Motor Symptoms of Parkinson’s

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi

Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease

Memories Encoded in DNA and Biological Reliques

French Mobile Diabetes Firm gets €17.5M to Build an Artificial Pancreas

A Norwegian Biotech is Aiming at Permanently Removing HPV Skin Infections

Watch Europe’s Rising Biotech Startups Battle it out at Refresh

Lab-Grown Bile Ducts Can Replace Liver Transplant in Mice

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Results are in from the First Human Trial of an Universal Cancer Vaccine

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Clara Rodríguez Fernández

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!